Research map: Tumor molecular age acceleration is associated with early progression in diffuse large B-cell lymphoma

Back to the article

Papers in this map

  1. Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma · Roland P. H. Schmitz · 2018 · 2327 citations · Cited by this paper
  2. Evolutionary considerations for risk stratification in TP53-variant myeloproliferative neoplasms · 2026 · Related
  3. Diffuse Large B-Cell Lymphoma · Laurie Helen Sehn · 2021 · 1211 citations · Cited by this paper
  4. Rbm5 sustains leukemia stem cells through a Myc-driven transcriptional circuitry · 2026 · Related
  5. Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report · Stuart Lacy · 2020 · 524 citations · Cited by this paper
  6. Cohesin haploinsufficiency and inv(16) cooperate to reinforce Fli1 gene transcriptional programs during acute myeloid leukemia initiation and maintenance · 2026 · Related
  7. Nonlinear dynamics of multi-omics profiles during human aging · Xiaotao Shen · 2024 · 487 citations · Cited by this paper
  8. Non-invasive multiparametric characterization of essential thrombocythemia, premyelofibrosis, and overt myelofibrosis · 2026 · Related
  9. The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma · Chloé Beate Steen · 2021 · 343 citations · Cited by this paper
  10. FATP2-mediated lipid metabolism enhances chimeric antigen receptor T-cell therapy resistance in B-cell acute lymphoblastic leukemia · 2026 · Related
  11. Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy · Chulin Sha · 2018 · 317 citations · Cited by this paper
  12. IKZF1N159S is associated with adverse outcomes in patients with myelodysplastic neoplasms · 2026 · Related
  13. Clinical and Biological Subtypes of B-cell Lymphoma Revealed by Microenvironmental Signatures · Nikita Kotlov · 2021 · 267 citations · Cited by this paper
  14. Prognostic impact of measurable residual disease in AML patients treated frontline with azacitidine and venetoclax: results from the French VENAURA registry · 2026 · Related
  15. DNA methylation‐based biological aging and cancer risk and survival: Pooled analysis of seven prospective studies · Pierre‐Antoine Dugué · 2017 · 237 citations · Cited by this paper
  16. Randomized phase 2 trial of CPX-351 vs. CLAG-M (cladribine, cytarabine, G-CSF, and mitoxantrone) for medically unfit adults with acute myeloid leukemia or other high-grade myeloid neoplasms · 2026 · Related
  17. Multidimensional single-cell analysis of human peripheral blood reveals characteristic features of the immune system landscape in aging and frailty · Oscar Junhong Luo · 2022 · 154 citations · Cited by this paper
  18. Stuck in traffic: CART cells targeting the tumor microenvironment in hematological malignancies, current advances and future perspectives · 2026 · Related
  19. Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials · Matthew J. Maurer · 2018 · 110 citations · Cited by this paper
  20. Unpacking the epigenetic landscape of acute lymphoblastic leukemia: resolving cellular heterogeneity and nutritional complexities · 2026 · Related
  21. Challenges and Opportunities in the Management of Diffuse Large B-Cell Lymphoma in Older Patients · Mengyang Di · 2020 · 85 citations · Cited by this paper
  22. The complex interplay between aging and cancer · Lucrezia A. Trastus · 2025 · 48 citations · Cited by this paper
  23. An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal Lymphomas · Leandro Venturutti · 2022 · 23 citations · Cited by this paper
  24. Practical microenvironment classification in diffuse large B cell lymphoma using digital pathology · Yuqing Wang · 2025 · 11 citations · Cited by this paper
  25. Untitled · Cited by this paper

Source: OpenAlex (CC0)